Alexandre de la Taille
MD, PHD.
Current positions
- Head of the Urology Department of the CHU Mondor, Assistance Publique des Hôpitaux de Paris, Créteil, France (since 2012)
- President of theFrench Association of Urology (2022-2025)
- Vice President of the Departmental Council of the Order of Physicians (2021-2024)
- Associate Editor of the World Journal of Urology
- President of the Association for Research on Prostate Diseases(www.iartp.org)
- Member of the TReCAP prostate cancer research team (EU-UPEC)
Diplomas
- Doctorate in Medicine in September 2000
- PHD December 2000
- Research Grant(Columbia University, New York-USA, November 1997 - October 1999)
- Certificates in Laparoscopy, Andrology, Statistics, Abdo-Pelvic Anatomy, Urodynamics
- ICH GCP Training 28/2/20
Price
- Matula Crystal Award - European Association of Urology 2006
- EAU Thesis Award 2001 - Sanofi-synthelabo - "Biomarkers of apoptosis in prostate cancer."
- First Prize in the 1999 AAU/Circon-ACMI Trial Competition "Cadherin T6, a novel cadherin family protein involved in the acquisition of therapeutic resistance in prostate cancer cells."
Teaching
- Responsible for teaching robotic surgery at Henri Mondor University Hospital
- Teaching robotic surgery with the Da Vinci system: kidney and prostate surgery in collaboration with Intuitive Surgical
- Organizer of congresses and symposiums in the field of robotic surgery and uro-oncology: UROP, UDOU, UCARE
- Teacher atIRCAD: surgical demonstrations by videoconference
- Collaboration with St. Jospeh Hospital and USEK (Lebanon), training of residents
Search
Professor Alexandre de la Taille started his research on circulating cells in prostate cancer in Professor Chopin's team and then at Columbia University with Professor Buttyan on markers of apoptosis in prostate cancer. He continued in France by taking the direction of the INSERMU977Eq07 team on biomarkers in prostate cancer. He is currently involved in the research on exosomes in prostate cancer within the TReCAP team of Pr Vacherot.
Organization of congresses
- Updates in Onco-Urology
- UROP Prostate 2022
- Association for Prostate Tumor Research
Publications
More than 540 original articles have been published on basic research work but also on the development of laparoscopic and robotic surgery. List of publications in MedLine; click here
Professor Alexandre de la Taille has participated in the writing of more than 12 book chapters and has been invited as a speaker or presented his work in the congresses of AFU, EAU, AUA, SLU (Lebanon), SIU, China, Tunisia, Morocco, Algeria, Italy, Switzerland, Syrian, Colombian, Argentina, Australia, Japan, United Arab Emirates, Turkey, Egypt, Romania, Portugal, England and the United States.
Didactic books
Prostate: we tell you everything
Functioning, ailments, health, sexuality, prevention.
Urology: Passing the ECNi
In perfect coherence with the DFASM program and the ECNi, this book brings together the fundamental knowledge in urology.
List of the last 20 articles as 1st author
- Let's ride against prostate cancer!
- Beware, urology and medicine are evolving (finally?)...
- Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study
- Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips or Low-energy Bipolar Coagulation? Low Energy
- Alpha-blockers or phytotherapy as first-line treatment of LUTS/BPH in general medicine: The PERSAT non-interventional study
- Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery
- How to prevent LUTS due to BPH development and progression
- Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy
- Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy
- Sometimes a Simple Old-Fashioned and Low Cost Pathological Parameter Can be Useful
- Comment on "secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot study"
- Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions
- Observational study CAPITAL and prescription of hormonotherapy by French urologists in daily practice
- Circumstances of prescription of hormone therapy for patients with prostate cancer
- Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia
- Open to debate. The motion: at least 18 cores are necessary to make a prostatic biopsy useful
- Progensa PCA3 test for prostate cancer detection
- Over the past decade, prostate needle biopsies have been studied widely
- Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)
- The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms (CTMH-AFU study)
List of the last 20 publications of the team
- Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study) April 6, 2024
- Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer March 27, 2024
- A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal Disparities March 12, 2024
- Urologists and Sustainability: The First Survey from the French Sustainability Working Group February 23, 2024
- Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review January 20, 2024
- REVIEW: "ISCHEMIC STROKE: From Fibrinolysis to Functional Recovery" Nanomedicine: Emerging Approaches to Treat Ischemic Stroke december 6, 2023
- BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model November 25, 2023
- Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study October 13, 2023
- Early detection of prostate cancer: Towards a new paradigm? October 7, 2023
- A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate Surgery August 28, 2023
- Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study) August 18, 2023
- Let's ride against prostate cancer! July 17, 2023
- Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial July 7, 2023
- Surgical and oncological management of renal medullary carcinoma in a young patient: a case report May 19, 2023
- Intraoperative complication of radical cystectomy for muscle-invasive bladder cancer: does the surgical approach matter? A retrospective multicenter study using the EAUiaiC classification February 27, 2023
- Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells February 25, 2023
- Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer February 11, 2023
- Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review February 1, 2023
- Microbubbles for human diagnosis and therapy January 30, 2023
- Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15) January 17, 2023